Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 3000 of 3173 entries
View as:

Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT00463372 Org: User:
Start: 10/31/06 End: 05/31/07 Due: 05/31/08

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT04006457 Org: User:
Start: 07/18/19 End: 01/23/26 Due: 01/23/27

Nasopharyngeal Streptococcus Pneumoniae Carriage

Phase: N/A Priority: Normal
NCT ID: NCT00471822 Org: User:
Start: 07/31/05 End: 12/31/10 Due: 12/31/11

Study Evaluating The Effect Of Ramipril On Urinary Protein Excretion In Renal Transplant Patients Converted To Sirolimus

Phase: N/A Priority: Normal
NCT ID: NCT00502242 Org: User:
Start: 12/31/07 End: 09/30/13 Due: 09/30/14

A Single Dose Escalation Study In Healthy Volunteers To Determine The Pharmacokinetics, Safety And Tolerability Of PF-05089771 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01259882 Org: User:
Start: 12/31/10 End: 09/30/11 Due: 09/30/12

A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649

Phase: N/A Priority: Normal
NCT ID: NCT02170012 Org: User:
Start: 07/31/14 End: 09/30/14 Due: 09/30/15

A Safety Study Of A Monoclonal Antibody Against A5B1 Integrin In Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00915278 Org: User:
Start: 09/30/09 End: 01/31/13 Due: 01/31/14

A Study To Assess The Effect Of Linezolid On QTc Interval

Phase: N/A Priority: Normal
NCT ID: NCT00795145 Org: User:
Start: 12/31/08 End: 03/31/09 Due: 03/31/10

Study of Bosutinib in Japanese Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03128411 Org: User:
Start: 05/15/17 End: 03/04/21 Due: 03/04/22

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00759161 Org: User:
Start: 11/30/07 End: 03/31/08 Due: 03/31/09

A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03372044 Org: User:
Start: 01/19/18 End: 04/04/18 Due: 04/04/19

Registry For Patients Treated With BeneFix In Usual Care Setting In Germany

Phase: N/A Priority: Normal
NCT ID: NCT00714415 Org: User:
Start: 01/31/08 End: 10/31/16 Due: 10/31/17

Food Effect Study PF-04136309

Phase: N/A Priority: Normal
NCT ID: NCT02598206 Org: User:
Start: 12/31/15 End: 05/31/16 Due: 05/31/17

An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00226811 Org: User:
Start: 01/31/06 End: 05/31/08 Due: 05/31/09

Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01603485 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo

Phase: N/A Priority: Normal
NCT ID: NCT01359150 Org: User:
Start: 09/30/11 End: 02/29/12 Due: 02/28/13

Drug Interaction Study To Investigate The Potential Effect Of Proton Pump Inhibitor On The Pharmacokinetics Of Palbociclib (PD-0332991)

Phase: N/A Priority: Normal
NCT ID: NCT01918176 Org: User:
Start: 09/30/13 End: 12/31/13 Due: 12/31/14

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Phase: N/A Priority: Normal
NCT ID: NCT00796666 Org: User:
Start: 05/31/09 End: 03/31/11 Due: 03/31/12

A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804

Phase: N/A Priority: Normal
NCT ID: NCT01313793 Org: User:
Start: 04/30/11 End: 05/31/11 Due: 05/31/12

A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00556998 Org: User:
Start: 06/30/08 End: 12/31/09 Due: 12/31/10

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

Phase: N/A Priority: Normal
NCT ID: NCT02135029 Org: User:
Start: 06/30/14 End: 11/30/15 Due: 11/30/16

Use of 852A in Metastatic Cutaneous Melanoma.

Phase: N/A Priority: Normal
NCT ID: NCT00189332 Org: User:
Start: 02/28/05 End: 08/31/06 Due: 08/31/07

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Phase: N/A Priority: Normal
NCT ID: NCT00117598 Org: User:
Start: 05/31/05 End: 01/31/11 Due: 01/31/12

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01461980 Org: User:
Start: 09/28/11 End: 05/08/14 Due: 05/08/15

A Study Of Three PF-05190457 Formulations In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01522807 Org: User:
Start: 09/30/11 End: 11/30/11 Due: 11/30/12